Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,774,000 | 2,584,000 | 2,078,000 | 980,000 | 4,128,000 |
| Depreciation Amortization | 786,000 | 593,000 | 401,000 | 199,000 | 897,000 |
| Accounts receivable | -172,000 | 95,000 | 120,000 | 167,000 | 681,000 |
| Accounts payable and accrued liabilities | -193,000 | -1,000 | -217,000 | -612,000 | -426,000 |
| Other Working Capital | -354,000 | 178,000 | -308,000 | -661,000 | 692,000 |
| Other Operating Activity | 1,708,000 | 678,000 | 267,000 | 551,000 | 295,000 |
| Operating Cash Flow | $3,549,000 | $4,127,000 | $2,341,000 | $624,000 | $6,267,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -612,000 | -459,000 | -279,000 | -137,000 | -491,000 |
| Net Acquisitions | -622,000 | -572,000 | -17,000 | N/A | -405,000 |
| Purchase Of Investment | -1,169,000 | -1,169,000 | -1,160,000 | -660,000 | -930,000 |
| Sale Of Investment | 1,477,000 | 1,460,000 | 300,000 | 0 | 2,705,000 |
| Other Investing Activity | 0 | -2,700,000 | 0 | 0 | 0 |
| Investing Cash Flow | $-926,000 | $-3,440,000 | $-1,156,000 | $-797,000 | $879,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 12,000 | -112,000 | -162,000 | -410,000 | -601,000 |
| Debt Repayment | -17,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 232,000 | 164,000 | 127,000 | 85,000 | 347,000 |
| Common Stock Repurchased | -665,000 | -352,000 | -353,000 | -329,000 | -320,000 |
| Dividend Paid | -2,661,000 | -1,987,000 | -1,314,000 | -641,000 | -2,555,000 |
| Other Financing Activity | -194,000 | -124,000 | 10,000 | 18,000 | -313,000 |
| Financing Cash Flow | $-3,293,000 | $-2,411,000 | $-1,692,000 | $-1,277,000 | $-3,442,000 |
| Exchange Rate Effect | -577,000 | -152,000 | -2,000 | -5,000 | -10,000 |
| Beginning Cash Position | 9,595,000 | 9,595,000 | 9,595,000 | 9,595,000 | 5,901,000 |
| End Cash Position | 8,348,000 | 7,719,000 | 9,086,000 | 8,140,000 | 9,595,000 |
| Net Cash Flow | $-1,247,000 | $-1,876,000 | $-509,000 | $-1,455,000 | $3,694,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,549,000 | 4,127,000 | 2,341,000 | 624,000 | 6,267,000 |
| Capital Expenditure | -612,000 | -459,000 | -279,000 | -137,000 | -491,000 |
| Free Cash Flow | 2,937,000 | 3,668,000 | 2,062,000 | 487,000 | 5,776,000 |